Impact of HO-2 Gene Suppression on Corneal Healing
Author Information
Author(s): Lars Bellner, Kiran A. Patil, Kirkland Castellano, Adna Halilovic, Michael W. Dunn, Michal Laniado Schwartzman
Primary Institution: New York Medical College
Hypothesis
Does localized suppression of HO-2 disrupt the cornea's innate anti-inflammatory and repair capabilities?
Conclusion
Suppressing HO-2 in the cornea delays healing, increases neovascularization, and leads to chronic inflammation.
Supporting Evidence
- Local injection of HO-2-specific shRNA reduced corneal HO-2 mRNA by 50%.
- Corneal re-epithelialization was delayed by 14%, 20%, and 12% at days 3, 4, and 7 after injury in HO-2 shRNA-treated mice.
- Neovascular response increased threefold and 3.5 fold at days 4 and 7 after injury in HO-2 shRNA-treated mice.
Takeaway
When a specific gene that helps the cornea heal is turned off, it takes longer for the cornea to heal and can cause more problems.
Methodology
The study used shRNA to silence HO-2 in mice and assessed corneal healing and inflammation through various measurements.
Limitations
The study primarily used a mouse model, which may not fully represent human corneal responses.
Participant Demographics
C57bl6 mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website